Supplementation with Selenium yeast on the prooxidant-antioxidant activities and anti-tumor effects in breast tumor xenograft-bearing mice

The Journal of Nutritional Biochemistry
Chih-Hung GuoPei-Chung Chen

Abstract

Selenium (Se) is essential for antioxidant activity involved in immune function and anti-carcinogenic action, whereas at higher concentrations, Se may have pro-oxidant properties. The present study was aimed at determining the effects of Se supplementation, as Se yeast, on oxidative stress in non-tumor/tumor tissues, as well as regulation of the apoptotic process, and immune responses in mice-bearing breast tumor xenografts. Female BALB/cByJNarl mice were divided into control (CNL and CNL-con), Se-supplemented control (CNL-HS, given as a single oral dose of 912 ng Se daily), breast tumor-bearing (TB and TB-con), TB-LS (228 ng Se), TB-MS (456 ng Se) and TB-HS (912 ng Se) groups. All mice were treated with/without Se for 14 days. A number of variables were further measured. Compared with the TB groups, tumor bearing mice with Se supplement had increased plasma Se concentrations, reduced erythrocyte Se-dependent glutathione peroxidase (GPx) activity and malondialdehyde (MDA) products and inhibited tumor growth. They have also higher Se concentrations in non-tumor and tumor tissues. Significantly elevated concentrations of MDA and reduced GPx activities, as well as increased anti-apoptotic bcl-2 and tumor suppressor p53 concentrati...Continue Reading

References

Oct 13, 2000·Breast Cancer : the Journal of the Japanese Breast Cancer Society·S Nagai, M Toi
Oct 4, 2002·Nutrition·Yun-Zhong FangGuoyao Wu
Apr 3, 2003·Nature Reviews. Cancer·S Perwez HussainCurtis C Harris
Jun 24, 2003·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·H TapieroK D Tew
Nov 13, 2003·Molecular and Cellular Biology·Salvador MacipStuart A Aaronson
Nov 4, 2004·The British Journal of Nutrition·Margaret P Rayman
May 24, 2005·Apoptosis : an International Journal on Programmed Cell Death·R X-D SongR J Santen
May 22, 2007·Molecular Cancer Therapeutics·Katherine M A RogersDaniel B Longley
Oct 10, 2008·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·Kuan-Der LeeMin-Chi Chen
Sep 30, 2009·International Journal of Oncology·Yayun LiangSalman M Hyder
Apr 14, 2010·Cancer Metastasis Reviews·Giovambattista PaniPaola Chiarugi
Sep 28, 2010·Archives of Toxicology·Jela BrozmanováMiroslav Chovanec
Oct 7, 2010·Annals of Oncology : Official Journal of the European Society for Medical Oncology·C A S FrancaA B R C Penna
Jun 28, 2012·Breast Cancer Research and Treatment·Holly R HarrisAlicja Wolk
Sep 22, 2012·Asian Pacific Journal of Cancer Prevention : APJCP·Naval Kishor YadavBidhan Chandra Koner
Jan 5, 2013·International Journal of Medical Sciences·Chih-Hung Guo, Chia-Liang Wang
Feb 23, 2013·Nutrients·Chih-Hung GuoPei-Chung Chen
Apr 25, 2013·International Journal of Cancer. Journal International Du Cancer·Yu-Chi ChenAndrea M Mastro
May 11, 2013·Nutrition and Cancer·Jagoda K WrobelMichal Toborek
Jun 15, 2013·Oncology Reports·Bruna Victorasso JardimDebora Ap Pires de Campos Zuccari

❮ Previous
Next ❯

Related Concepts

Related Feeds

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis

BCL-2 Family Proteins

BLC-2 family proteins are a group that share the same homologous BH domain. They play many different roles including pro-survival signals, mitochondria-mediated apoptosis and removal or damaged cells. They are often regulated by phosphorylation, affecting their catalytic activity. Here is the latest research on BCL-2 family proteins.

Breast Tumorigenesis

Breast tumorigenesis involves the production or formation of tumor(s) in breast tissue. Discover the latest research on breast tumorigenesis here.